Introduction Positron emission tomography-magnetic resonance (PETMR) is a new hybrid imaging modality that has recently been introduced in clinical practice for oncologic imaging and is increasingly being used in various clinical indications. PET-MR unifies the complementary capabilities of magnetic resonance imaging (MRI) and PET in a single imaging modality. Excellent anatomical and morpholog...

Lung cancer has for many years been a disease with poor prognosis and still is. However, new techniques for diagnostic procedures and the introduction of new treatment alternatives give hope that the near future will bring maybe not cure for all patients but the possibility to turn the disease from a killer with a short life expectancy to a disease of chronic nature for which various treatment ...

Non-alcoholic fatty liver disease (NAFLD) encompasses the often benign non-alcoholic fatty liver (NAFL) characterized by hepatic steatosis with or without mild inflammation and the more complicated non-alcoholic steatohepatitis (NASH) with lobular inflammation and hepatocellular ballooning which can be complicated by fibrosis. Independent associates for the presence of liver fibrosis in patient...

Whole body (WB) imaging plays an essential role in the management of lymphoma patients, including defining the full extent of the disease at baseline, allowing for an accurate staging and therefore an adapted treatment strategy, assessing treatment response and detecting relapse. Contrast-enhanced computed tomography (CT) has long been the imaging technique most commonly used for staging and fo...

To the Editor: In the 1st issue of HJNM for 2012 we read with interest a case where 3 different cancers were detected [1]. Synchronous second malignancy can be incidentally detected in routine fluorine-18-fluoro-deoxy-glucose positron emission tomography/computed tomography (18F-FDG PET/ CT) imaging in approximately 1% of cancer patients with lungs being the most frequent site [2]. We report th...

My interest in imaging breast cancer with PET began in the late 1980s with my, and many others’, gradual recognition that the radiotracer 18F-FDG, originally designed for brain imaging, was actually a promising visceral tumor imaging agent (1–3). The early contributions of the late Ludwig Strauss to colorectal cancer imaging with PETwere quite informative at that time (4). Although at that stag...

Cancer is a genetic disease. Mutated oncogenes and tumor suppressor proteins activate signaling networks that underlie many of the characteristic hallmarks of cancer. Cancer is also a metabolic disease. Long before the identification of oncogenes, Otto Warburg showed that cancer cells consume large amounts of glucose relative to normal cells, forming the basis for 18FFDG PET imaging. Instead of...

With an incidence of 20.5 per 100,000 people each year, tumors of the central nervous system are a heterogeneous group, with meningiomas (35.5%) and gliomas (30%) being the most common (1). Although 97% of meningiomas are benign, 54% of gliomas are highly malignant glioblastomas of World Health Organization (WHO) grade IV. Survival rates are 35.7% at 1 y and 4%–7% at 5 y for glioblastoma, 60%–8...

The Extramedullary Plasmacytomas (EP) are rare tumors originating from plasmacells of the soft tissues outside of the bone. For a correct diagnosis biopsy is mandatory and CT or MRI is necessary. We report a case of a 62 year-old man, who underwent to otolaryngologist visit for nose bleeding. A peduncolated right palatine tonsillar lesion was diagnosed. The nasopharyngeal examination revealed a...

lung cancer remains the leading cause of cancer related deaths in australia and worldwide. Despite recent advances in screening, diagnosis and treatment, long-term overall survival of lung cancer remains poor. surgery, either alone or as part of a multimodality treatment regimen, plays an important role in the management of patients with nonsmall cell lung cancer. complete surgical resection of...